HRK Protein
Introduction
Hrk Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@harris2000]
title: HRK Protein [@sattler2001]
description: Pro-apoptotic BH3-only protein that triggers mitochondrial [apoptosis](/entities/apoptosis) and is implicated in neurodegenerative diseases. [@yuan2008]
--- [@lee2015]
<div class="infobox infobox-protein"> [@perezrojas2011]
<table>
<tr><th colspan="2" class="infobox-header">HRK Protein</th></tr>
<tr><td class="label">Protein Name</td><td>Harakiri protein (Hrvk, DP5)</td></tr>
<tr><td class="label">Gene</td><td>[HRK](/genes/HRK)</td></tr>
<tr><td class="label">UniProt ID</td><td>[O00139](https://www.uniprot.org/uniprot/O00139)</td></tr>
<tr><td class="label">PDB ID</td><td>1WJX, 2L9Z</td></tr>
<tr><td class="label">Molecular Weight</td><td>~9.5 kDa</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Mitochondria (outer membrane), cytosol</td></tr>
<tr><td class="label">Protein Family</td><td>Bcl-2 family (BH3-only proteins)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
...HRK Protein
Introduction
Hrk Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@harris2000]
title: HRK Protein [@sattler2001]
description: Pro-apoptotic BH3-only protein that triggers mitochondrial [apoptosis](/entities/apoptosis) and is implicated in neurodegenerative diseases. [@yuan2008]
--- [@lee2015]
<div class="infobox infobox-protein"> [@perezrojas2011]
<table>
<tr><th colspan="2" class="infobox-header">HRK Protein</th></tr>
<tr><td class="label">Protein Name</td><td>Harakiri protein (Hrvk, DP5)</td></tr>
<tr><td class="label">Gene</td><td>[HRK](/genes/HRK)</td></tr>
<tr><td class="label">UniProt ID</td><td>[O00139](https://www.uniprot.org/uniprot/O00139)</td></tr>
<tr><td class="label">PDB ID</td><td>1WJX, 2L9Z</td></tr>
<tr><td class="label">Molecular Weight</td><td>~9.5 kDa</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Mitochondria (outer membrane), cytosol</td></tr>
<tr><td class="label">Protein Family</td><td>Bcl-2 family (BH3-only proteins)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
Harakiri (HRK), also known as DP5 (Death Protein 5), is a pro-apoptotic BH3-only protein that belongs to the Bcl-2 family. HRK functions as a sensitizer BH3-only protein, directly activating the intrinsic (mitochondrial) apoptosis pathway by binding to anti-apoptotic Bcl-2 family members and neutralizing their survival function [@imaizumi1997]. Originally identified as a neuron-specific apoptosis inducer, HRK has been implicated in various forms of neuronal cell death associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and stroke [@harris2000].
Structure
HRK is a small, single-domain protein with a canonical BH3 death domain:
| Feature | Description |
|---------|-------------|
| Length | 91 amino acids (full-length) |
| BH3 domain | aa 29-53; critical for pro-apoptotic activity |
| Transmembrane domain | aa 68-87; mitochondrial targeting |
| Structure | Alpha-helical bundle (NMR structure available) |
The BH3 domain forms an amphipathic alpha-helix that binds with high affinity to the hydrophobic grooves of anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xL, Mcl-1, Bcl-w) [@sattler2001]. Unlike some other BH3-only proteins, HRK lacks a clear activation mechanism and appears to be constitutively active once expressed.
Normal Function
Apoptosis Induction
HRK triggers apoptosis through the intrinsic pathway:
Expression: HRK expression is induced by various pro-apoptotic stimuli including:
- Calcium influx
- Oxidative stress
- Growth factor withdrawal
- [Amyloid-beta](/proteins/amyloid-beta) toxicity
Mitochondrial translocation: The C-terminal transmembrane domain targets HRK to mitochondria
Bcl-2 binding: HRK binds to anti-apoptotic Bcl-2 proteins via its BH3 domain, displacing and activating pro-apoptotic Bax/Bak
Mitochondrial outer membrane permeabilization (MOMP): Bax/Bak activation leads to cytochrome c release and caspase activationNeuronal Specificity
HRK is predominantly expressed in [neurons](/entities/neurons), particularly:
- Hippocampal neurons
- Cortical pyramidal neurons
- Cerebellar Purkinje cells
- Substantia nigra dopaminergic neurons
This neuronal specificity makes HRK particularly relevant to neurodegenerative processes.
Role in Disease
Alzheimer's Disease
HRK plays a significant role in amyloid-beta-induced neuronal apoptosis:
- Up-regulation: Amyloid-beta treatment induces HRK expression in neurons
- Synaptic toxicity: HRK contributes to synaptic spine loss
- Therapeutic target: Inhibiting HRK may protect against amyloid-beta neurotoxicity [@yuan2008]
Parkinson's Disease
- Dopaminergic neuron vulnerability: HRK is induced in models of dopaminergic neuron death
- Oxidative stress: Mitochondrial toxins that induce oxidative stress upregulate HRK
- Interaction with [alpha-synuclein](/proteins/alpha-synuclein): HRK may mediate synuclein-induced apoptosis [@lee2015]
Stroke and Ischemia
- Ischemic injury: HRK expression increases dramatically after cerebral ischemia
- Stroke outcomes: HRK knockout mice show reduced infarct sizes and improved functional outcomes
- Therapeutic potential: HRK inhibitors may reduce post-stroke neuronal loss [@perezrojas2011]
ALS (Amyotrophic Lateral Sclerosis)
- Motor neuron death: HRK is induced in models of motor neuron degeneration
- Mutant SOD1: Linked to HRK upregulation in SOD1-linked ALS
Cancer
Paradoxically, HRK functions as a tumor suppressor in some contexts:
- Low expression: Many cancers show reduced HRK expression
- Apoptotic resistance: Restoring HRK sensitizes cancer cells to chemotherapy
Regulation of HRK Expression
Transcriptional Regulation
| Stimulus | Mechanism | Outcome |
|----------|-----------|---------|
| Calcium influx | Calcineurin/NFAT pathway | Transcription activation |
| c-Jun N-terminal kinase (JNK) | Phosphorylation of transcription factors | Increased expression |
| p53 | Direct transcriptional activation | Pro-apoptotic response |
| ER stress | CHOP-mediated activation | [Unfolded protein response](/entities/unfolded-protein-response) |
Post-translational Regulation
- Phosphorylation: JNK-mediated phosphorylation enhances HRK pro-apoptotic activity
- Ubiquitination: Some evidence for proteasomal degradation
- Alternative splicing: Produces different isoforms with varying activity
Therapeutic Targeting
HRK is a promising therapeutic target:
Neuroprotective Strategies
- BH3 mimetics: Small molecules that mimic BH3 domains can displace HRK from Bcl-2
- Gene therapy: siRNA approaches to knock down HRK expression
- Blocking peptides: Cell-penetrating peptides that inhibit HRK-Bcl-2 interaction
Drug Development
- Selectivity: Targeting HRK specifically (vs. other BH3-only proteins) is challenging
- [Blood-brain barrier](/entities/blood-brain-barrier): Therapeutic agents must penetrate the CNS
- Combination therapy: May enhance efficacy of other neuroprotective agents
Interactions
| Partner | Interaction Type | Functional Outcome |
|---------|-----------------|-------------------|
| Bcl-2 | Direct binding | Neutralizes anti-apoptotic function |
| Bcl-xL | Direct binding | Neutralizes anti-apoptotic function |
| Mcl-1 | Direct binding | Neutralizes anti-apoptotic function |
| Bax | Indirect | Displaces Bax for activation |
| Bak | Indirect | Displaces Bak for activation |
- Knockout mice: Hrk knockout mice are viable and resistant to some apoptotic stimuli
- Transgenic mice: Neuron-specific overexpression models
- Chemical inhibitors: BH3 mimetics (e.g., ABT-737) can inhibit HRK-Bcl-2 interaction
Background
The study of Hrk Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cross-Links
- [HRK Gene](/hrk-gene)
- [Apoptosis Pathways](/mechanisms/apoptosis-parkinsons-disease)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
See Also
- [BCL2 Protein](/proteins/bcl2-protein)
- [BCLXL Protein](/proteins/BCLXL-Protein)
- [BAX Protein](/proteins/bax)
- [BAK1 Protein](/proteins/bak1-protein)
- [NOXA Protein](/proteins/noxa-protein)
- [PUMA Protein](/proteins/puma-protein)
External Links
- [UniProt: HRK](https://www.uniprot.org/uniprot/O00139)
- [NCBI Protein: HRK](https://www.ncbi.nlm.nih.gov/protein/NP_001073340)
- [GeneCards: HRK](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HRK)
- [PDB: HRK Structures](https://www.rcsb.org/structure/1WJX)
References
[Imaizumi et al., Molecular cloning of HRK (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/9322708/)
[Unknown, Harris & Thompson, BH3-only proteins in neurodegeneration (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11013138/)
[Sattler et al., Structure of HRK BH3 domain (2001) (2001)](https://doi.org/10.1016/S1097-2765(01)
[Yuan et al., HRK in Alzheimer's disease (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18614019/)
[Lee et al., HRK in Parkinson's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25849456/)
[Perez-Rojas et al., HRK in cerebral ischemia (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21364560/)